Oxford textbook of medicine. (Record no. 4691)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01496nam a22002057a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20191226215930.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 150213b xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780199592869 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | WB 100 O 2010 |
245 ## - TITLE STATEMENT | |
Title | Oxford textbook of medicine. |
250 ## - EDITION STATEMENT | |
Edition statement | 5th ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | India : |
Name of publisher, distributor, etc. | Oxford, |
Date of publication, distribution, etc. | 2010. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | iix, 3715 p. : |
Other physical details | ill. : |
Dimensions | 28 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes index |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Radioisotope-based molecular imaging probes provide unprecedented insight into biochemistry and function involved in both normal and disease states of living systems, with unbiased in vivo measurement of regional radiotracer activities offering very high specificity and sensitivity. No other molecular imaging technology including functional magnetic resonance imaging (fMRI) can provide such high sensitivity and specificity at a tracer level. The applications of this technology can be very broad ranging from drug development, pharmacokinetics, clinical investigations, and finally to routine diagnostics in radiology. The design and the development of radiopharmaceuticals for molecular imaging studies using PET/MicroPET or SPECT/MicroSPECT are a unique challenge. This book is intended for a broad audience and written with the main purpose of educating the reader on various aspects including potential clinical utility, limitations of drug development, and regulatory compliance and approvals. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | drugs |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Warrell, David A |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | National Library of Medicine Classification |
Koha item type | Books |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Date last checked out | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
National Library of Medicine Classification | FNPH LIBRARY | FNPH LIBRARY | 13/02/2015 | 1 | WB 100 O 2010 | 09650 | 22/04/2015 | 02/04/2015 | 13/02/2015 | Books |